JeffreyJohnBednarskiIIMD

Pediatric Hematology & Oncology • Saint Louis, MO

Associate Professor of Pediatrics, Hematology and Oncology, Washington University School of Medicine

Join to view full profile

Dr. Bednarski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bednarski's full profile

Already have an account?

Office
1 Childrens Pl
# Div
Saint Louis, MO 63110
Phone+1 314-454-6018

Fax+1 844-621-4392

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Pediatric Hematology/Oncology, 2006 - 2009
Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 2003 - 2006
University of Michigan Medical SchoolClass of 2003

Certifications & Licensure

MO State Medical License 2009 - 2025
IL State Medical License 2003 - 2006
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors Start of enrollment: 2012 Oct 26
Completed
Phase 1
Immune Disorder HSCT Protocol Start of enrollment: 2013 Mar 01
Recruiting
Phase 2
Cytokine-induced Memory-like NK Cells in Combination With Chemotherapy in Pediatric Patents With Refractory or Relapsed AML Start of enrollment: 2023 Jun 30
Withdrawn
Phase 2
Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hematologic Malignancies Start of enrollment: 2022 Nov 03
Recruiting
Phase 1
Roles: Principal Investigator, Contact
Registry Study of Revcovi Treatment in Patients With ADA-SCID Start of enrollment: 2019 Jun 25
Completed
Roles: Contact, Principal Investigator
Conditioning SCID Infants Diagnosed Early Start of enrollment: 2018 Oct 22
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML Start of enrollment: 2024 May 15
Recruiting
Phase 1, Phase 2
Roles: Sub-Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

57 citations
Enhancer Sequence Variants and Transcription-Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B-Cell Lymphoma
Olivia I. Koues, Rodney A. Kowalewski, Li-Wei Chang, Sarah C. Pyfrom, Jennifer A. Schmidt
Immunity. 2015-01-20
45 citations
Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey
Alice Y. Chan, Jennifer W. Leiding, Xuerong Liu, Brent R. Logan, Lauri Burroughs
Frontiers in Immunology. 2020-02-21
94 citations
At the intersection of DNA damage and immune responses
Jeffrey J. Bednarski, Barry P. Sleckman
Nature Reviews. Immunology. 2019-04-01

Abstracts/Posters

The Tetraspanin CD53 Regulates Early B Cell Development By Promoting IL-7R Signaling
Jeffrey J. Bednarski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Adoptively Transferred Donor-Derived Cytokine Induced Memory-like NK Cells Persist and Induce Remission in Pediatric Patient with Relapsed Acute Myeloid Leukemia after...
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Bclaf1 Promotes Maintenance and Self-Renewal of Fetal Hematopoietic Stem Cells
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018